FILE:BMY/BMY-8K-20050831171933.txt.gz
EVENTS:	Other Events	Financial Statements and Exhibits
TEXT:
ITEM: Other Events
ITEM: Financial Statements and Exhibits
 
 
 
 
 
 
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (General Instruction A.2. below):
see
 
 
 
 
 
Item 8.01. Other Events.
 
On August 31, 2005, Bristol-Myers Squibb Company issued a press release announcing that it has completed the previously announced sale of its U.S. and Canadian Consumer Medicines business to Novartis AG. A copy of the press release is attached to this report as Exhibit 99.1.
 
Item 9.01. Financial Statements and Exhibits.
 
 
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 

Exhibit 99.1
 
 
 
 
(NEW YORK, August 31, 2005)  Bristol-Myers Squibb Company (NYSE: BMY) today reported that it has completed the previously announced sale of its U.S. and Canadian Consumer Medicines business to Novartis AG (NYSE: NVS).
 
As previously disclosed, the transaction includes rights to Bristol-Myers Squibb's U.S. over-the-counter brands in Latin America, Europe, Middle East and Africa. The transfers of these rights are targeted to be completed by the end of the year.
 
Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.
 


